News for hackers. Stuff that matters.
Re:FDA Designates MM120 (LSD) Breakthrough Therapy for Gener... by fragmede on Saturday March 09, 2024 @02:02PM (#39653927)
I can't speak for GP, but when it's combined with talk therapy, the ketamine allows the body to lower its defenses so that talk therapy can more successfully be administered, and the combination of the two is what leads to long lasting effects, long after the ketamine has worn off. Ketamine let's the patient open up so talk therapy can get at the underlying issue and resolve that, in ways that talk therapy alone can't solve because the patient's flight /fight response/anxiety won't let them let their guard down to really talk about it.
Re:FDA Designates MM120 (LSD) Breakthrough Therapy for Gener... by xk_id on Saturday March 09, 2024 @08:30PM (#39656042)
Completely wrong, what you wrote is true for MDMA, not ketamine.
Re:FDA Designates MM120 (LSD) Breakthrough Therapy for Gener... by fragmede on Saturday March 09, 2024 @08:34PM (#39656060)
why not both?
Re:FDA Designates MM120 (LSD) Breakthrough Therapy for Gener... by xk_id on Saturday March 09, 2024 @08:47PM (#39656113)
Because it’s literally wrong and has nothing to do with how Ketamine works or with how it’s used therapeutically according to any and all sources.
Re:FDA Designates MM120 (LSD) Breakthrough Therapy for Gener... by fragmede on Saturday March 09, 2024 @08:53PM (#39656140)
Interesting! Can you link some? I'd love to read them.
Re:FDA Designates MM120 (LSD) Breakthrough Therapy for Gener... by xk_id on Saturday March 09, 2024 @09:02PM (#39656168)
Check out the other comments in this thread, i wrote a summary and someone else wrote a personal account. If you want to read more you could search on g scholar for a recent review paper on ketamine infusion therapy.